2011

• Kozako T, Akimoto M, Toji S, White Y, Suzuki S, Arima T, Suruga Y,Matsushita K, Shimemo H, Soeda S, Kubota R, Izumo S, Uozumi K, Arima N. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic Tlymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders. J Med Virol. 83:501-509, 2011
• Kozako T, Hirata S, Shimizu Y, Satoh Y, Yoshimitsu M, White Y, Lemonnier F, Shimeno H, Soeda S, Arima N. Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant. FEBS Journal, 278:1358-1366, 2011
• Hamasaki T, Toyama M, Aoyama H, White Y, Okamoto M, Arima N, Hashimoto Y, and Baba M. Selective inhibition of HTLV-1-infected cell proliferation by a novel tetramethylnaphthalene derivative. Anticancer Research 31:2241-2248, 2011
• Uenogawa K, Hatta Y, Arima N, Hayakawa S, Sawada , Aizawa S, Yamamoto T, Takeuchi J. Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma Int. J. Mol. Med. 28:835-839, 2011
• Kozako T, Yoshimitsu M, Akimoto M, White Y, Matushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N. PD-1/PD-L1 Pathway-Mediated Immune Responses Against Human T-Lymphotropic Virus Type I in HAM/TSP and Carriers with Collagen Diseases. Human Immunology, 72:1001-1006, 2011.
• White Y, Hamada T, Yoshimitsu M, Nakashima M, Hachiman M, Kozako T, Matsushita K, Uozumi K, Suzuki S, Kofune H, Furukawa T, Arima N. Novel cytotoxic isolated from Jamaicn Hyptis verticillata jacq induces apoptosis and overcomes multidrug resistance. Anticancer Research, 31:4251-4258, 2011.